Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Medtronic plc

NYSE

Market Cap.

114.09B

Avg. Volume

6.11M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Medtronic plc!

Still processing it, give me a bit more time...

Medtronic plc News

Medtronic plc Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Devices
medtronic.com

About Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic plc Earnings & Revenue

Medtronic plc Financials

Table Compare

Compare MDT metrics with:

   

Earnings & Growth

MDT

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

MDT

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

MDT

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

MDT

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Medtronic plc Income

Medtronic plc Balance Sheet

Medtronic plc Cash Flow

Medtronic plc Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioBuy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Medtronic plc Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.76

Payment DateDividendFrequency
2024-04-120.69Quarterly
2024-01-120.69Quarterly
2023-10-130.69Quarterly
2023-07-140.69Quarterly
2023-04-140.68Quarterly

Historical Market Cap

Shares Outstanding

Medtronic plc Executives

NameRole
Mr. Geoffrey Straub MarthaChairman of the Board & Chief Executive Officer
Mr. Robert J. W. ten HoedtExecutive Vice President & President of Global Regions
Ms. Karen L. ParkhillExecutive Vice President & Chief Financial Officer
Mr. Ivan K. FongExecutive Vice President, General Counsel & Secretary
Mr. Sean M. SalmonExecutive Vice President & President of Cardiovascular Portfolio
NameRoleGenderDate of BirthPay
Mr. Geoffrey Straub MarthaChairman of the Board & Chief Executive OfficerMale19701.79M
Mr. Robert J. W. ten HoedtExecutive Vice President & President of Global RegionsMale19601.24M
Ms. Karen L. ParkhillExecutive Vice President & Chief Financial OfficerFemale1965992.24K
Mr. Ivan K. FongExecutive Vice President, General Counsel & SecretaryMale1961985.57K
Mr. Sean M. SalmonExecutive Vice President & President of Cardiovascular PortfolioMale1965900.97K

Medtronic plc Insider Trades

Date1 May
NamePowell Kendall J
RoleDirector
TransactionDisposed
TypeF-InKind
Shares192
Date1 May
NameOLEARY DENISE M
RoleDirector
TransactionDisposed
TypeF-InKind
Shares192
Date1 May
NameNABEL ELIZABETH G
RoleDirector
TransactionDisposed
TypeF-InKind
Shares192
Date1 May
NameLofton Kevin E
RoleDirector
TransactionDisposed
TypeF-InKind
Shares192
Date1 May
NameHOGAN RANDALL J
RoleDirector
TransactionDisposed
TypeF-InKind
Shares192
DateNameRoleTransactionTypeShares
1 MayPowell Kendall JDirectorDisposedF-InKind192
1 MayOLEARY DENISE MDirectorDisposedF-InKind192
1 MayNABEL ELIZABETH GDirectorDisposedF-InKind192
1 MayLofton Kevin EDirectorDisposedF-InKind192
1 MayHOGAN RANDALL JDirectorDisposedF-InKind192

Discover More

Streamlined Academy

Medtronic plc

NYSE

Market Cap.

114.09B

Avg. Volume

6.11M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Medtronic plc News

Medtronic plc Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Medtronic plc Earnings & Revenue

Medtronic plc Income

Medtronic plc Balance Sheet

Medtronic plc Cash Flow

Medtronic plc Financials Over Time

Medtronic plc Executives

NameRole
Mr. Geoffrey Straub MarthaChairman of the Board & Chief Executive Officer
Mr. Robert J. W. ten HoedtExecutive Vice President & President of Global Regions
Ms. Karen L. ParkhillExecutive Vice President & Chief Financial Officer
Mr. Ivan K. FongExecutive Vice President, General Counsel & Secretary
Mr. Sean M. SalmonExecutive Vice President & President of Cardiovascular Portfolio
NameRoleGenderDate of BirthPay
Mr. Geoffrey Straub MarthaChairman of the Board & Chief Executive OfficerMale19701.79M
Mr. Robert J. W. ten HoedtExecutive Vice President & President of Global RegionsMale19601.24M
Ms. Karen L. ParkhillExecutive Vice President & Chief Financial OfficerFemale1965992.24K
Mr. Ivan K. FongExecutive Vice President, General Counsel & SecretaryMale1961985.57K
Mr. Sean M. SalmonExecutive Vice President & President of Cardiovascular PortfolioMale1965900.97K

Medtronic plc Insider Trades

Date1 May
NamePowell Kendall J
RoleDirector
TransactionDisposed
TypeF-InKind
Shares192
Date1 May
NameOLEARY DENISE M
RoleDirector
TransactionDisposed
TypeF-InKind
Shares192
Date1 May
NameNABEL ELIZABETH G
RoleDirector
TransactionDisposed
TypeF-InKind
Shares192
Date1 May
NameLofton Kevin E
RoleDirector
TransactionDisposed
TypeF-InKind
Shares192
Date1 May
NameHOGAN RANDALL J
RoleDirector
TransactionDisposed
TypeF-InKind
Shares192
DateNameRoleTransactionTypeShares
1 MayPowell Kendall JDirectorDisposedF-InKind192
1 MayOLEARY DENISE MDirectorDisposedF-InKind192
1 MayNABEL ELIZABETH GDirectorDisposedF-InKind192
1 MayLofton Kevin EDirectorDisposedF-InKind192
1 MayHOGAN RANDALL JDirectorDisposedF-InKind192

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
medtronic.com

About Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Medtronic plc!

Still processing it, give me a bit more time...

Medtronic plc Financials

Table Compare

Compare MDT metrics with:

   

Earnings & Growth

MDT

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

MDT

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

MDT

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

MDT

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Medtronic plc Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.76

Payment DateDividendFrequency
2024-04-120.69Quarterly
2024-01-120.69Quarterly
2023-10-130.69Quarterly
2023-07-140.69Quarterly
2023-04-140.68Quarterly

Medtronic plc Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioBuy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More